Accreditation/Credit Designation

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEU) under the ACPE universal activity number 0290-0000-21-265-H01-P. The activity is available for CE credit through July 15, 2022.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Physicians’ Education Resource®, LLC, and Pharmacy Times Continuing Education™. Physicians’ Education Resource®, LLC is accredited by the ACCME to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 2.0 Contact Hours.

This CE activity is also offered free online at www.ajmc.com/ce and at www.PharmacyTimes.org/go/ IBD-AJMC, where you will be directed to the activity in its entirety, including the online pretest and posttest, activity evaluation, and request for credit.

Acknowledgment of Support

This activity is supported by an educational grant from American Regent.

An American Journal of Managed Care® Supplement Evolving Evidence-Based Treatment Guidelines for Iron Deficiency Anemia in Inflammatory Bowel Disease: Considerations in Managed Care

Release Date: July 15, 2021
Expiration Date: July 15, 2022

Activity Overview

Iron deficiency anemia (IDA) is closely linked to inflammatory bowel disease (IBD). Treatment often consists of iron replacement therapy, and novel intravenous (IV) iron formulations have impacted the management of patients with both IBD and IDA. Managed care professionals must understand the role of IV iron in treating patients with IBD and IDA, as well as safety and efficacy considerations. This activity will review the role of IV iron replacement in IBD and IDA and focus on the economic burden of these disease states and the impact of  IV iron on healthcare resource use.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from American Regent.
 

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This activity is intended for pharmacists managed care professionals, physicians and nurses.
 
Pharmacists and those seeking pharmacy credits are encouraged to register with our partner, Pharmacy Times Continuing Education (https://www.pharmacytimes.org/) for the online version of this supplement at: www.PharmacyTimes.org/go/IBD-AJMC
 

Learning Objectives

Upon completion of this activity, participants should be able to:
•   Examine the biologic pathways relevant to iron hemostasis in inflammatory bowel disease (IBD) as well as appropriate monitoring of iron status.
•   Compare iron replacement therapies, including risks and benefits, for the treatment of patients with IBD and iron deficiency.
•   Explore the health-related quality of life and economic burden of iron deficiency anemia in relation to the evolving evidence-based treatment protocols for patients with IBD and iron deficiency to improve outcomes and efficiently allocate healthcare resources.

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible entities.

Faculty

Nicole Bohm, PharmD, BCPS
Associate Professor and Clinical Pharmacy Specialist, Internal Medicine
Department of Clinical Pharmacy and Outcomes Sciences
College of Pharmacy
Medical University of South Carolina
Charleston, SC

Disclosures: Nicole Bohm, PharmD, BCPS, has the following relevant financial relationships with commercial interests to disclose: Consultant: Wolters Kluwer, TRC, Pharmacist’s Letter.

Jeenal Patel, PharmD, BCGP
Associate Director
Formulary Design and Strategy
Oscar Health
Lakeland, FL

Disclosures: Jeenal Patel, PharmD, BCGP, has no relevant financial relationships with commercial interests to disclose.

Medical Writing and Editorial Support

Brittany Hoffmann-Eubanks, PharmD, MBA
Owner
Banner Medical, LLC
Frankfort, IL

Disclosures: Brittany Hoffmann-Eubanks, PharmD, MBA, has no relevant financial relationships with commercial interests to disclose.

Jenna Wood, PharmD
Clinical Pharmacist
Columbus, OH

Disclosures: Jenna Wood, PharmD, has no relevant financial relationships with commercial interests to disclose.

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy

According to the disclosure policy of The American Journal of Managed Care® and Pharmacy Times Continuing Education™, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education™ to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

In accordance with ACCME guidelines, PER® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Disclosure of Unapproved/Off-Label Use

The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and they are advised to consult prescribing information for these products.

The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.
 
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care®Pharmacy Times Continuing Education™, or any of the companies that provided commercial support for this CE activity.

Signed disclosures are on file at the office of The American Journal of Managed Care®, Cranbury, New Jersey.
 

Educational Disclaimer

CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
 

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
    123
45678910
11121314151617
18192021222324
25262728293031
Filter By